Onderneming Talis Biomedical Corporation
Aandelen
TLIS
US87424L2079
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,9 USD | -1,11% | +4,71% | +19,46% |
Vakgebied
Aantal werknemers: 99
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Grant
80,7
%
| 1 | 24,1 % | 2 | 80,7 % | +48,45% |
Antigen Tests Products
19,3
%
| 4 | 75,9 % | 0 | 19,3 % | -88,72% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 5 | 100,0 % | 2 | 100,0 % | -55,65% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Kelley
CEO | Chief Executive Officer | 52 | 01-09-20 |
Director of Finance/CFO | 51 | 01-01-22 | |
Kim Popovits
BRD | Director/Board Member | 65 | 31-07-20 |
Emily Faucette
IRC | Investor Relations Contact | - | - |
Gillian Green
SEC | Corporate Secretary | - | - |
Matthew Pepe
HRO | Human Resources Officer | - | 01-05-21 |
Jill Green
LAW | General Counsel | - | 01-01-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Matthew Posard
BRD | Director/Board Member | 56 | 01-03-16 |
Randal Scott
BRD | Director/Board Member | 66 | 01-01-14 |
Kim Popovits
BRD | Director/Board Member | 65 | 31-07-20 |
Robert Kelley
CEO | Chief Executive Officer | 52 | 01-09-20 |
Heiner Dreismann
BRD | Director/Board Member | 69 | 19-05-23 |
Rustem Ismagilov
FOU | Founder | 50 | 01-06-13 |
Raymond Cheong
BRD | Director/Board Member | 42 | 01-06-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 821 986 | 1 670 630 ( 91,69 %) | 0 | 91,69 % |
Aandeel B | 0 | 29 863 674 | 0 | 0 |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,46% | 16,22 mln. | |
-1,42% | 41,52 mld. | |
+42,15% | 39,9 mld. | |
+1,97% | 38,83 mld. | |
-14,19% | 26,05 mld. | |
+1,82% | 23,78 mld. | |
-24,55% | 18,26 mld. | |
-4,07% | 11,65 mld. | |
+21,36% | 11,53 mld. | |
+8,20% | 11,2 mld. |
- Beurs
- Aandelen
- Koers TLIS
- Onderneming Talis Biomedical Corporation